Europe Sinus Tissue Resection Market (2022 - 2030) Size, Share & Trends Analysis Report By Product (Endoscopes, Ethmoid Forceps, Nasal Scissors, Curetts), By End-use, By Country, And Segment Forecasts

Report Overview

The Europe sinus tissue resection market size was valued at USD 153.0 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 6.2% from 2022 to 2030. The increasing prevalence of chronic sinusitis, rising preference for minimally invasive surgical procedures, and the launch of technologically advanced products are some of the major factors driving the market during the forecast period. The COVID-19 pandemic resulted in a temporary fall in the sales of sinus tissue resection products. The imposition of lockdowns and guidelines imposed by governments to curb the spread of the virus resulted in a reduced number of procedures being performed. Moreover, owing to a change in healthcare priorities with the focus being on the COVID-19 infected patients, the market for sinus tissue resection observed a negative impact on the overall sales in the first half of 2020.

In addition, due to the lockdowns and restrictions, there was a severe disruption in the supply chain, which also resulted in a negative impact. The pandemic also resulted in reduced patient visits to hospitals and clinics in order to avoid contracting the virus by the patients. This led to a lesser number of patients seeking treatment, thereby reducing the sales of sinus tissue resection products during the pandemic.

However, the gradual opening of economies and various plans and strategies set up by the government to fight a similar situation in the future is helping the market to grow. Moreover, with the governments in various countries offering vaccination programs, the situation is further under control and reflects that the pandemic may soon come to an end. This represents a favorable scenario for the growth of the industry during the forecast period.

The rising prevalence of chronic sinusitis and significant regional differences in sinus-related cases in European countries are anticipated to boost the demand for sinus tissue resection devices during the projection period. Similarly, the rising number of allergic rhinitis cases is expected to have a similar impact on the market. For instance, according to a research article published in the World Allergy Organization Journal, in 2018, Germany observed a high prevalence of allergies in the country, with about 20% of its population having at least one allergy and only about 10% opting to adequately treat it.

Moreover, there has been a significant rise in the incidence of chronic diseases such as asthma, rhinitis, and allergies in the European region. In 2019, 9.9% of the population in Portugal and 8.2% of the total population in Sweden were suffering from asthma. Such a rise in the prevalence of asthma is anticipated to surge the demand for sinus tissue resection devices.

Product Insights

The endoscopes segments held the largest revenue share of over 30.0% in 2021. Endoscopes help in improving airflow through the nose and symptoms associated with sinuses. They also help in the reduction and severity of sinus infections, thus making it the leading segment in terms of revenue, and this trend is expected to continue during the forecast period. Based on product, the market is segmented into endoscopes, ethmoid forceps, nasal scissors, currets, and others.                                            

The currets segment is expected to expand at a CAGR of 6.36% during the assessment period. This is attributed to the availability of various shapes of the blades, which expands the application scope for a large number of indications. The growing prevalence of chronic sinusitis and more number of people opting for sinus tissue resection procedures are further expected to fuel the growth of currets in the coming years.

End-use Insights

The hospital segment accounted for the largest revenue share of over 30.0% in 2021 owing to a large number of procedures being performed in hospitals and the continued preference of patients to visit hospitals in comparison to other settings. This is, in turn, making it the dominant segment in terms of end-use. On the basis of end-use, the market is fragmented into hospitals, ambulatory surgical centers, clinics, and others.

The ambulatory surgical centers segment is expected to expand at a significant CAGR of 6.35% during the forecast years. This is because of the advantages associated with ambulatory surgical centers such as reduced in-patient time, which reduces the overall cost incurred on the additional stay post surgeries. Moreover, a rise in the number of new ambulatory surgical centers in the region is boosting the segment growth.

Country Insights

Germany held the largest revenue share of over 15.0% in 2021. Factors contributing to the market growth in the country include a well-established healthcare infrastructure and system, increasing prevalence of allergic rhinitis in the country, and easy availability of the products. For instance, according to a research article published in World Allergy Organization Journal, in 2018, Germany observed a high prevalence of allergies in the country, with about 20% of its population having at least one allergy and only about 10% opting to adequately treat it.

Switzerland is expected to witness significant growth during the projection period due to the country’s increased focus on the healthcare and medical device industries. The country is one of the most important locations for the medical device industry. This makes Switzerland a very attractive market.

Key Companies & Market Insights

Key players are keen on expanding their market presence by implementing strategic initiatives such as acquisitions, partnerships, and collaborations. For instance, in May 2022, B. Braun Melsungen AG’s surgical division Aesculap strengthened its partnership with True Digital Surgery, a California-based company that has expertise in robotically controlled 3D digital visualization. This has helped the company to strengthen its surgical segment post-acquisition. Some prominent players in the Europe sinus tissue resection market include:

• Medtronic

• Intellus Medical, Inc.

• B.Braun Melsungen

• Integra Lifesciences

• Karl Storz

• Bausch & Lomb Incorporated

Europe Sinus Tissue Resection Market Report Scope

Europe Sinus Tissue Resection Market Segmentation

This report forecasts revenue growth at the regional and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2017 to 2030. For the purpose of this study, Grand View Research has segmented the Europe sinus tissue resection market report on the basis of product, end-use, and country:

• Product Outlook (Revenue, USD Million, 2017 - 2030)

  • Endoscopes

  • Ethmoid Forceps

  • Nasal Scissors

  • Curetts

  • Others

• End-use Outlook (Revenue, USD Million, 2017 - 2030)

  • Hospitals

  • Ambulatory Surgical Centers

  • Clinics

  • Others

• Country Outlook (Revenue, USD Million, 2017 - 2030)

  • U.K.

  • Germany

  • France

  • Italy

  • Spain

  • Switzerland

  • Israel

  • Sweden

  • Norway

  • Greece

  • Austria

  • Netherlands

  • Portugal

  • Luxembourg

  • Denmark

  • Iceland

  • Ireland

  • Belgium

  • Finland